An RNA-only CRISPR-Cas9-Based Therapy to Eliminate Latent Infection of HIV

Xu Tan of Tsinghua University in China will harness the genome-editing power of the CRISPR-Cas9 system to eliminate latent HIV infection and provide a proof-of-concept for a potential cure for HIV infection.

More information about China Tsinghua University - Grand Challenges Explorations

An RNA-only CRISPR-Cas9-Based Therapy to Eliminate Latent Infection of HIV

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

.css-1nxq281{overflow:hidden;display:inline-block;}.css-1nxq281 span{display:inline-block;}Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

Great ideas come from everywhere.